143 related articles for article (PubMed ID: 12904991)
1. PTEN methylation and expression in glioblastomas.
Baeza N; Weller M; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2003 Nov; 106(5):479-85. PubMed ID: 12904991
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
4. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.
Idoate MA; Echeveste J; Diez-Valle R; Lozano MD; Aristu J
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):736-46. PubMed ID: 24417635
[TBL] [Abstract][Full Text] [Related]
6. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
[TBL] [Abstract][Full Text] [Related]
7. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
8. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
9. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
[TBL] [Abstract][Full Text] [Related]
12. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
[TBL] [Abstract][Full Text] [Related]
13. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in pediatric high-grade astrocytomas.
Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS
Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
18. PTEN promoter is methylated in a proportion of invasive breast cancers.
Khan S; Kumagai T; Vora J; Bose N; Sehgal I; Koeffler PH; Bose S
Int J Cancer; 2004 Nov; 112(3):407-10. PubMed ID: 15382065
[TBL] [Abstract][Full Text] [Related]
19. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
20. Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.
Martinez R; Schackert HK; von Kannen S; Lichter P; Joos S; Schackert G
Brain Pathol; 2003 Oct; 13(4):598-607. PubMed ID: 14655763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]